These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21089547)

  • 21. Gene-based vaccines: recent technical and clinical advances.
    Ulmer JB; Wahren B; Liu MA
    Trends Mol Med; 2006 May; 12(5):216-22. PubMed ID: 16621717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
    Takaoka A; Wang Z; Choi MK; Yanai H; Negishi H; Ban T; Lu Y; Miyagishi M; Kodama T; Honda K; Ohba Y; Taniguchi T
    Nature; 2007 Jul; 448(7152):501-5. PubMed ID: 17618271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
    Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
    Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The innate immune response to DNA.
    Vilaysane A; Muruve DA
    Semin Immunol; 2009 Aug; 21(4):208-14. PubMed ID: 19497760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.
    Wheeler M; Cortez-Gonzalez X; Frazzi R; Zanetti M
    Int Rev Immunol; 2006; 25(3-4):83-97. PubMed ID: 16818366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus-like particle vaccines and adjuvants: the HPV paradigm.
    Buonaguro FM; Tornesello ML; Buonaguro L
    Expert Rev Vaccines; 2009 Oct; 8(10):1379-98. PubMed ID: 19803760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-free vaccines?
    Krieg AM
    Nat Biotechnol; 2007 Mar; 25(3):303-5. PubMed ID: 17344883
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
    Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
    Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-erating self DNA.
    Bauer S
    Nat Immunol; 2006 Jan; 7(1):13-5. PubMed ID: 16357851
    [No Abstract]   [Full Text] [Related]  

  • 31. T cells: A killer cytokine.
    Bird L
    Nat Rev Immunol; 2015 Aug; 15(8):466-7. PubMed ID: 26205580
    [No Abstract]   [Full Text] [Related]  

  • 32. CpG motifs to modulate innate and adaptive immune responses.
    Vollmer J
    Int Rev Immunol; 2006; 25(3-4):125-34. PubMed ID: 16818368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent injection of a rhabdovirus-specific DNA vaccine with a polyvalent, oil-adjuvanted vaccine delays the specific anti-viral immune response in Atlantic salmon, Salmo salar L.
    Skinner LA; LaPatra SE; Adams A; Thompson KD; Balfry SK; McKinley RS; Schulte PM
    Fish Shellfish Immunol; 2010 Apr; 28(4):579-86. PubMed ID: 20045062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in vaccine adjuvants.
    Singh M; O'Hagan D
    Nat Biotechnol; 1999 Nov; 17(11):1075-81. PubMed ID: 10545912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-26 AMPs up the T(H)17 arsenal.
    Lee JS; Cua DJ
    Nat Immunol; 2015 Sep; 16(9):897-8. PubMed ID: 26287587
    [No Abstract]   [Full Text] [Related]  

  • 36. TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine.
    Coban C; Horii T; Akira S; Ishii KJ
    Expert Rev Vaccines; 2010 Jul; 9(7):775-84. PubMed ID: 20624050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.
    Sasaki S; Tsuji T; Asakura Y; Fukushima J; Okuda K
    Anticancer Res; 1998; 18(5D):3907-15. PubMed ID: 9854503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvants and autoimmunity.
    Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopharmacology of CpG DNA.
    Dalpke A; Zimmermann S; Heeg K
    Biol Chem; 2002 Oct; 383(10):1491-500. PubMed ID: 12452427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.